Skip to main
G
G logo

Genpact (G) Stock Forecast & Price Target

Genpact (G) Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 29%
Buy 0%
Hold 71%
Sell 0%
Strong Sell 0%

Bulls say

Genpact Ltd is positioned for positive financial performance, driven by a strong bookings momentum contributing to low-double digit revenue growth in the long term. The anticipated improvement in demand for the company’s core business process management and analytics services, as Global 2000 firms seek to streamline operations, is expected to accelerate growth as macroeconomic conditions normalize. Additionally, management’s focus on returning capital to shareholders through buybacks and dividends suggests a commitment to enhancing shareholder value while navigating a robust deal pipeline and increasing demand for AI-based solutions.

Bears say

Genpact Ltd faces a negative outlook primarily due to challenges in employee retention within key regions, which could hinder revenue growth. Furthermore, economic shocks, such as those stemming from the Covid-19 pandemic, may impede client decision-making processes, further impacting the company's financial performance. Additionally, unfavorable currency movements present a risk to both the top and bottom lines, potentially exacerbating profitability concerns.

Genpact (G) has been analyzed by 7 analysts, with a consensus rating of Buy. 29% of analysts recommend a Strong Buy, 0% recommend Buy, 71% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Genpact and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Genpact (G) Forecast

Analysts have given Genpact (G) a Buy based on their latest research and market trends.

According to 7 analysts, Genpact (G) has a Buy consensus rating as of Oct 15, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $50.14, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $50.14, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Genpact (G)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.